Rüdiger P. Laubender
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 13
- Colorectal Cancer Treatments and Studies 12
- General Dentistry top 5%
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Cancer Research top 5%
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 7
-
- Inflammatory Bowel Disease 6
-
- Lung Cancer Treatments and Mutations 5
-
- Cardiac pacing and defibrillation studies 3
-
- Pancreatitis Pathology and Treatment 3
- Co-authors
- Volker HeinemannBurkhard GökeStefan BoeckDominik Paul ModestStephan BrandMichael HaasFlorian BeigelAlexander Becker
- Cited by
- OncologyGeneral DentistryHepatology
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Rüdiger P. Laubender
60 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 115
- Oncology 803
- General Dentistry 51
- Hepatology 175
- Cancer Research 314
- Epidemiology 650
Countries citing papers authored by Rüdiger P. Laubender
This map shows the geographic impact of Rüdiger P. Laubender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger P. Laubender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger P. Laubender more than expected).
Fields of papers citing papers by Rüdiger P. Laubender
This network shows the impact of papers produced by Rüdiger P. Laubender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger P. Laubender. The network helps show where Rüdiger P. Laubender may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rüdiger P. Laubender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 101 | |
| 2 | 2014 | 10 | |
| 3 | 2014 | 29 | |
| 4 | 2013 | 8 | |
| 5 | 2013 | 35 | |
| 6 | 2013 | 18 | |
| 7 | 2013 | 31 | |
| 8 | 2012 | 25 | |
| 9 | 2012 | 77 | |
| 10 | 2012 | 80 | |
| 11 | 2011 | 23 | |
| 12 | 2011 | 21 | |
| 13 | 2011 | 38 | |
| 14 | 2011 | 6 | |
| 15 | 2010 | 142 | |
| 16 | 2010 | 26 | |
| 17 | 2010 | 63 | |
| 18 | 2010 | 45 | |
| 19 | 2009 | 62 | |
| 20 | 2009 | 256 |
About Rüdiger P. Laubender
Rüdiger P. Laubender is a scholar working on Hepatology, Oncology and Gastroenterology, having authored 60 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Neuroendocrine Tumor Research Advances (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Inflammatory Bowel Disease (6 papers), Lung Cancer Treatments and Mutations (5 papers), Cardiac pacing and defibrillation studies (3 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Oncology (803 citations), General Dentistry (51 citations) and Hepatology (175 citations). Rüdiger P. Laubender has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Volker Heinemann, Burkhard Göke, Stefan Boeck, Dominik Paul Modest, Stephan Brand, Michael Haas, Florian Beigel, Alexander Becker, Cornelia Tillack and Thomas Kirchner.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.